In this episode, we hear from Andy Molnar, CEO at the Digital Therapeutics Alliance. Andy dives into what they are working on to propel the DTx industry forward, and the international scope of his work in Europe, Asia Pacific and beyond.

We also discuss the recent trends with commercial payers and reimbursements - or lack thereof - and much more.

Key Takeaway:

Be sure to check out the link to the DTx Value Assessment and Integration Guide put together by the DTx Alliance. It is designed to support healthcare decision makers as they assess and integrate DTx products into clinical use settings. 

Guest Links and Resources:

Host Links:

Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram